Literature DB >> 12890803

Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer.

M R Pillai1, P Chacko, L A Kesari, P G Jayaprakash, H N Jayaram, A C Antony.   

Abstract

AIMS: Folate receptors (FRs) mediate cellular uptake of folates in many cancer cells and in folate deficiency heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) mediates translational upregulation of FR in cultured cervical cancer cells. hnRNP-E1 can also interfere with human papillomavirus 16 (HPV-16) viral capsid protein synthesis (and thereby HPV proliferation) in vitro. This study aimed to evaluate prospectively the relevance of FR and hnRNP-E1 expression in the normal cervix, cervical dysplasia, and cancer.
METHODS: Cervical tissues from 12 women with normal histology and 69 consecutive women with varying grades of cervical dysplasia and cancer were prospectively evaluated for immunohistochemical expression of FR, hnRNP-E1, proliferating cell nuclear antigen (PCNA), and HPV. There were 22 women with low grade squamous intraepithelial lesions (LGSIL), 22 with high grade squamous intraepithelial lesions (HGSIL), and 25 with invasive cervical carcinoma.
RESULTS: Among normal subjects, 100% and 92% expressed hnRNP-E1 and FR, respectively. FR expression decreased from 91% in LGSIL to 68% and 64% in women with HGSIL and cancer, respectively. Similarly, hnRNP-E1 expression decreased from 86% in LGSIL to 68% and 40% in HGSIL and cancer, respectively. There was a highly significant positive correlation between the extent of FR and hnRNP-E1 expression, and an inverse correlation between HPV infection and hnRNP-E1 expression during progression of cervical dysplasia to cancer.
CONCLUSION: These results are consistent with a hypothesis that reduced hnRNP-E1 expression may be permissive for HPV proliferation and progression to cervical cancer, and support the need for prospective longitudinal studies of hnRNP-E1 expression in HPV-16 infected women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890803      PMCID: PMC1770025          DOI: 10.1136/jcp.56.8.569

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  38 in total

1.  Pernicious papillomavirus infection.

Authors:  R D Burk
Journal:  N Engl J Med       Date:  1999-11-25       Impact factor: 91.245

2.  Quantitative tests for human papillomavirus.

Authors:  C Johnston
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

3.  Evidence that a specific interaction between an 18-base cis-element in the 5'-untranslated region of human folate receptor-alpha mRNA and a 46-kDa cytosolic trans-factor is critical for translation.

Authors:  X L Sun; A C Antony
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

4.  Isolation and characterization of a folate receptor from human placenta.

Authors:  A C Antony; C Utley; K C Van Horne; J F Kolhouse
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

5.  Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells.

Authors:  M McHugh; Y C Cheng
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

6.  Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.

Authors:  A M Josefsson; P K Magnusson; N Ylitalo; P Sørensen; P Qwarforth-Tubbin; P K Andersen; M Melbye; H O Adami; U B Gyllensten
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

7.  Estimates of the worldwide incidence of 25 major cancers in 1990.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

8.  Proliferating cell nuclear antigen expression and the progression of cervical intraepithelial neoplasia.

Authors:  S Lakshmi; M Nair; T Rajalakshmi; P Jayaprakash; M Nair; M Pillai
Journal:  Oncol Rep       Date:  1996-11       Impact factor: 3.906

9.  Telomerase, p53 and human papillomavirus infection in the uterine cervix.

Authors:  P Nair; P G Jayaprakash; M K Nair; M R Pillai
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

10.  Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation.

Authors:  M R Pillai; A L Kesari; V G Chellam; J Madhavan; P Nair; M K Nair
Journal:  Pathol Res Pract       Date:  1998       Impact factor: 3.250

View more
  25 in total

1.  DNA polymerase η is regulated by poly(rC)-binding protein 1 via mRNA stability.

Authors:  Cong Ren; Seong-Jun Cho; Yong-Sam Jung; Xinbin Chen
Journal:  Biochem J       Date:  2014-12-15       Impact factor: 3.857

2.  Possible novel roles of poly(rC)-binding protein 1 in SH-SY5Y neurocytes: an analysis using a dynamic Bayesian network.

Authors:  Li-Rong Huo; Jian-Tao Liang; Jun-Hua Zou; Lan-Ying Wang; Qi Li; Xiao-Min Wang
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

3.  3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end.

Authors:  Arindam Chaudhury; George S Hussey; Philip H Howe
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

Review 4.  Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles.

Authors:  Arindam Chaudhury; Praveen Chander; Philip H Howe
Journal:  RNA       Date:  2010-06-28       Impact factor: 4.942

5.  Evidence Favoring a Positive Feedback Loop for Physiologic Auto Upregulation of hnRNP-E1 during Prolonged Folate Deficiency in Human Placental Cells.

Authors:  Ying-Sheng Tang; Rehana A Khan; Suhong Xiao; Deborah K Hansen; Sally P Stabler; Praveen Kusumanchi; Hiremagalur N Jayaram; Aśok C Antony
Journal:  J Nutr       Date:  2017-03-01       Impact factor: 4.798

6.  RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3.

Authors:  Wei Han; Zhongshuai Xin; Zhiqiang Zhao; Wen Bao; Xihua Lin; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

7.  PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells.

Authors:  Tong Zhang; Xian-Hong Huang; Lan Dong; Deqing Hu; Changhui Ge; Yi-Qun Zhan; Wang-Xiang Xu; Miao Yu; Wei Li; Xiaohui Wang; Liujun Tang; Chang-Yan Li; Xiao-Ming Yang
Journal:  Mol Cancer       Date:  2010-04-02       Impact factor: 27.401

8.  Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.

Authors:  Aśok Antony; Ying-Sheng Tang; Rehana A Khan; Mangatt P Biju; Xiangli Xiao; Qing-Jun Li; Xin-Lai Sun; Hiremagalur N Jayaram; Sally P Stabler
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

9.  Expression of poly(C)-binding protein 1 (PCBP1) in NSCLC as a negative regulator of EMT and its clinical value.

Authors:  Yifei Liu; Ling Gai; Jian Liu; Yuan Cui; Yan Zhang; Jia Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  PCBP1 is an important mediator of TGF-β-induced epithelial to mesenchymal transition in gall bladder cancer cell line GBC-SD.

Authors:  Hang-Yu Zhang; Ke-Feng Dou
Journal:  Mol Biol Rep       Date:  2014-06-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.